Jeffrey E. Miller, Ph.D.

Chief Scientific & Chief Executive Officer

Meghna Bhatnagar, M.B.A.
Chief Financial Officer

Jay H. Shaw, Ph.D.
Director of Clinical Product Development

David Dunn
Director of Regulatory Affairs

Donald Huffman
Director of Operations

James B. Isaacs, Jr., J.D.
Licensing and Contracts Counsel

Gary R. Clouse, J.D.
Senior Legal Counsel, Special Projects

Jordan Thornes
Quality Assurance Manager

Jeffrey E. Miller, Ph.D. - Chairman
Chief Scientific & Chief Executive Officer
Invivoscribe Technologies, Inc.

Gary R. Clouse , J.D.
Founding Partner
Isaacs Clouse Crose & Oxford
Senior Legal Counsel, Special Projects
Invivoscribe Technologies, Inc.

James B. Isaacs, Jr., J.D.
Founding Partner

Isaacs Clouse Crose & Oxford
Licensing and Contracts Counsel
Invivoscribe Technologies, Inc.

Mitchell Kronenberg, Ph.D.

President & Chief Scientific Officer

The La Jolla Institute for Allergy & Immunology

Hardwick Simmons, M.B.A.
Lead Director & Chairman Audit Committee
Raymond James Financial, Inc.
Director, Lions Gate Entertainment Corp.
Former CEO of the NASDAQ Stock Market, Inc.
Former President & CEO of Prudential Securities, Inc.

Stephen S. Wilson, Ph.D.

Vice President & Chief Technology Officer
The La Jolla Institute for Allergy & Immunology

Mitchell Kronenberg, Ph.D. - Chairman
President & Chief Scientific O
fficer
The La Jolla Institute for Allergy & Immunology


Jeffrey E. Miller, Ph.D.
Chief Scientific & Chief Executive Officer
Invivoscribe Technologies, Inc.

Stephen S. Wilson, Ph.D.
Vice President & CTO

The La Jolla Institute for Allergy & Immunology